OUR MISSION:
To partner with healthcare providers, payers, patients and advocacy groups to eradicate colorectal cancer.

Learn More

Cologuard: the first and only FDA approved stool DNA noninvasive colorectal cancer screening test.*

Learn More about Cologuard
*For average risk individuals only. Click the link above and talk to your doctor to see if Cologuard is right for you.

Latest News

Exact Sciences Announces Mayo Clinic as First Healthcare System to Offer Cologuard®

Stool-based DNA (sDNA) screening test for colorectal cancer to be available by prescription to patients MADISON, Wis. & ROCHESTER, Minn.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ:EXAS) today announced that Mayo Clinic will be the first health system to offer Cologuard®, the first and only Food and Drug Administration (FDA) approved,...Read more

FDA Approves Exact Sciences’ Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test

MADISON, WI – Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69...Read more

Be Seen, Get Screened
1 in 3 is not getting screened for colon cancer. Let's bring everyone out of hiding and in to get screened. Join us on Be Seen, Get Screened to help spread the word.

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.

Go To ExactLabs.com

FOR OUR INVESTORS

View updates on upcoming conference appearances, company news, financial reports and more.

Learn More